{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:21:57Z","timestamp":1791408117093,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>NOTCH receptor 3 (NOTCH3) is known to regulate the transcription of oncogenes or tumor suppressor genes, thereby playing a crucial role in tumor development, invasion, maintenance, and chemotherapy resistance. However, the specific mechanism of how NOTCH3 drives immune infiltration in gastrointestinal cancer remains uncertain. The expression of NOTCH3 was analyzed through Western blot, PCR, Oncomine database, and the Tumor Immune Estimation Resource (TIMER) site. Kaplan\u2013Meier plotter, PrognoScan database, and gene expression profile interactive analysis (GEPIA) were used to assess the impact of NOTCH3 on clinical prognosis. The correlation between NOTCH3 expression and immune infiltration gene markers was investigated using TIMER and GEPIA. NOTCH3 was found to be commonly overexpressed in various types of gastrointestinal tumors and was significantly associated with poor prognosis. Furthermore, the expression level of NOTCH3 showed a significant correlation with the tumor purity of gastrointestinal tumors and the extent of immune infiltration by different immune cells. Our findings suggest that NOTCH3 may act as a crucial regulator of tumor immune cell infiltration and can serve as a valuable prognostic biomarker in gastrointestinal cancers.<\/jats:p>","DOI":"10.1038\/s41598-024-65036-x","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:05:15Z","timestamp":1718971515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["NOTCH3 as a prognostic biomarker and its correlation with immune infiltration in gastrointestinal cancers"],"prefix":"10.1038","volume":"14","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"65036_CR1","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1002\/cam4.3940","volume":"10","author":"ND Arhin","year":"2021","unstructured":"Arhin, N. D. et al. Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients. Cancer Med. 10, 4269\u20134281 (2021).","journal-title":"Cancer Med."},{"key":"65036_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA: a Cancer J. Clin."},{"key":"65036_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ymthe.2019.11.021","volume":"28","author":"J Xiao","year":"2020","unstructured":"Xiao, J. et al. miR-639 Expression is silenced by DNMT3A-mediated hypermethylation and functions as a tumor suppressor in liver cancer cells. Mol. Ther. J. Am. Soc. Gene Ther. 28, 587\u2013598 (2020).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"65036_CR4","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1002\/ctm2.467","volume":"11","author":"C Cheng","year":"2021","unstructured":"Cheng, C. et al. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression. Clin. Transl. Med. 11, e467 (2021).","journal-title":"Clin. Transl. Med."},{"key":"65036_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"L Topalian Suzanne","year":"2015","unstructured":"Topalian Suzanne, L., Drake Charles, G. & Pardoll, D. M. Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer Cell 27, 450\u2013461 (2015).","journal-title":"Cancer Cell"},{"key":"65036_CR6","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1007\/s13346-021-01018-0","volume":"11","author":"S Aghlara-Fotovat","year":"2021","unstructured":"Aghlara-Fotovat, S. et al. Targeting the extracellular matrix for immunomodulation: Applications in drug delivery and cell therapies. Drug Deliv. Transl. Res. 11, 2394\u20132413 (2021).","journal-title":"Drug Deliv. Transl. Res."},{"key":"65036_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential. Cell 161, 205\u2013214 (2015).","journal-title":"Cell"},{"issue":"1","key":"65036_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40425-018-0349-3","volume":"6","author":"YK Chae","year":"2018","unstructured":"Chae, Y. K. et al. Current landscape and future of dual anti-CTLA4 and PD-1\/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC). J. Immunother. Cancer. 6(1), 39 (2018).","journal-title":"J. Immunother. Cancer."},{"key":"65036_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","volume":"65","author":"DB Page","year":"2014","unstructured":"Page, D. B. et al. Immune modulation in cancer with antibodies. Ann. Rev. Med. 65, 185\u2013202 (2014).","journal-title":"Ann. Rev. Med."},{"key":"65036_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"65036_CR11","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.3390\/ijms22126309","volume":"22","author":"EM Nowosielska","year":"2021","unstructured":"Nowosielska, E. M. et al. Effects of a unique combination of the whole-body low dose radiotherapy with inactivation of two immune checkpoints and\/or a heat shock protein on the transplantable lung cancer in mice. Int. J. Mol. Sci. 22, 6309 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"65036_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/1078-0432.CCR-12-2625","volume":"19","author":"EJ Lipson","year":"2012","unstructured":"Lipson, E. J. et al. Durable cancer regression off-treatment and effective Reinduction therapy with an anti-PD-1 antibody. Clin. Cancer Res. 19, 462\u2013468 (2012).","journal-title":"Clin. Cancer Res."},{"key":"65036_CR13","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520. https:\/\/doi.org\/10.1056\/NEJMoa1500596 (2015).","journal-title":"N. Engl. J. Med."},{"key":"65036_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray, S. J. Notch signalling: A simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678\u2013689 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65036_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","volume":"17","author":"SJ Bray","year":"2016","unstructured":"Bray, S. J. Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17, 722\u2013735 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65036_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/15384101.2015.1127474","volume":"15","author":"C-F Chen","year":"2016","unstructured":"Chen, C.-F. et al. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells. Cell Cycle 15, 432\u2013440 (2016).","journal-title":"Cell Cycle"},{"key":"65036_CR17","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3892\/or.2015.3731","volume":"33","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. Oncol. Rep. 33, 1402\u20131410 (2015).","journal-title":"Oncol. Rep."},{"issue":"5","key":"65036_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/030089161009600518","volume":"96","author":"H Liu","year":"2010","unstructured":"Liu, H., Cao, Y. D., Ye, W. X. & Sun, Y. Y. Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells. Tumori. 96(5), 751\u2013755 (2010).","journal-title":"Tumori."},{"key":"65036_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1634\/theoncologist.2017-0677","volume":"23","author":"Z Aburjania","year":"2018","unstructured":"Aburjania, Z. et al. The role of notch3 in cancer. The Oncologist 23, 900\u2013911 (2018).","journal-title":"The Oncologist"},{"issue":"3","key":"65036_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/biom10030485","volume":"10","author":"S Hosseini-Alghaderi","year":"2020","unstructured":"Hosseini-Alghaderi, S. & Baron, M. Notch3 in development, health and disease. Biomolecules 10(3), 485 (2020).","journal-title":"Biomolecules"},{"issue":"1","key":"65036_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6(1), 1\u20136 (2004).","journal-title":"Neoplasia"},{"key":"65036_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno, H., Kitada, K., Nakai, K. & Sarai, A. PrognoScan: A new database for meta-analysis of the prognostic value of genes. BMC Med Genom. 2, 18 (2009).","journal-title":"BMC Med Genom."},{"key":"65036_CR23","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JG Smith","year":"2010","unstructured":"Smith, J. G. et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958\u2013968 (2010).","journal-title":"Gastroenterology"},{"key":"65036_CR24","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1158\/1078-0432.CCR-09-1431","volume":"15","author":"RN Jorissen","year":"2009","unstructured":"Jorissen, R. N. et al. Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal cancer. Clin. Cancer Res. 15, 7642\u20137651 (2009).","journal-title":"Clin. Cancer Res."},{"key":"65036_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-3-8","volume":"3","author":"A Sboner","year":"2010","unstructured":"Sboner, A. et al. Molecular sampling of prostate cancer: A dilemma for predicting disease progression. BMC Med. Genom. 3, 1\u20132 (2010).","journal-title":"BMC Med. Genom."},{"key":"65036_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-008-0183-2","volume":"116","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res. Treat. 116, 303\u2013309 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"65036_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1471-2164-9-239","volume":"9","author":"S Loi","year":"2008","unstructured":"Loi, S. et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genom. 9, 239 (2008).","journal-title":"BMC Genom."},{"key":"65036_CR28","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1073\/pnas.0907011107","volume":"107","author":"S Loi","year":"2010","unstructured":"Loi, S. et al. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor\u2013positive breast cancer. Proc. Nat. Acad. Sci. U. S. A. 107, 10208\u201310213 (2010).","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"65036_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00277-020-04358-y","volume":"100","author":"Y-H Wang","year":"2021","unstructured":"Wang, Y.-H. et al. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125. Ann. Hematol. 100, 487\u2013498 (2021).","journal-title":"Ann. Hematol."},{"key":"65036_CR30","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","volume":"112","author":"KH Metzeler","year":"2008","unstructured":"Metzeler, K. H. et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112, 4193\u20134201 (2008).","journal-title":"Blood"},{"key":"65036_CR31","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198\u20135208 (2008).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"65036_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123(3), 725\u2013731 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"65036_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu, T. & Dai, Y. Tumor microenvironment and therapeutic response. Cancer Lett. 387, 61\u201368 (2017).","journal-title":"Cancer Lett."},{"key":"65036_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"issue":"21","key":"65036_CR35","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77(21), e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"issue":"W1","key":"65036_CR36","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"65036_CR37","doi-asserted-by":"publisher","first-page":"6664791","DOI":"10.1155\/2021\/6664791","volume":"2021","author":"K Yan","year":"2021","unstructured":"Yan, K. et al. Coexpressed genes that promote the infiltration of m2 macrophages in melanoma can evaluate the prognosis and immunotherapy outcome. J. Immunol. Res. 2021, 6664791 (2021).","journal-title":"J. Immunol. Res."},{"key":"65036_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fonc.2014.00341","volume":"4","author":"M Teodorczyk","year":"2015","unstructured":"Teodorczyk, M. & Schmidt, M. H. H. Notching on Cancer\u00e2\u20acTMs door: notch signaling in brain tumors. Front. Oncol. 4, 341 (2015).","journal-title":"Front. Oncol."},{"key":"65036_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","volume":"66","author":"LW Ellisen","year":"1991","unstructured":"Ellisen, L. W. et al. TAN-1, the human homolog of the drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649\u2013661 (1991).","journal-title":"Cell"},{"key":"65036_CR40","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2016.5","volume":"35","author":"G Franciosa","year":"2016","unstructured":"Franciosa, G. et al. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression. Oncogene 35, 4741\u20134751 (2016).","journal-title":"Oncogene"},{"key":"65036_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.574937","author":"Y Cui","year":"2021","unstructured":"Cui, Y. et al. NOTCH3 is a prognostic factor and is correlated with immune tolerance in gastric cancer. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.574937 (2021).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65036-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:23:16Z","timestamp":1718972596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["65036"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-65036-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14327"}}